TRAPANI, DARIO
TRAPANI, DARIO
Dipartimento di Oncologia ed Emato-Oncologia
Grading of recommendations, assessment, development and evaluations concept 7: issues and insights linking guideline recommendations to trustworthy essential medicine lists
2024 T. Piggott, L. Moja, K. Jenei, T. Kredo, N. Skoetz, R. Banzi, D. Trapani, T. Leong, M. Mccaul, J.N. Lavis, E.A. Akl, F. Nonino, A. Iorio, J. Laurson-Doube, B.D. Huttner, H.J. Schünemann
Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems
2024 D. Horgan, M. Van den Bulcke, U. Malapelle, G. Troncone, N. Normanno, E.D. Capoluongo, A. Prelaj, C. Rizzari, D. Trapani, J. Singh, M. Kozaric, J. Longshore, M. Ottaviano, S. Boccia, G. Pravettoni, I. Cattaneo, N. Malats, R. Buettner, K. Lekadir, F. de Lorenzo, P. Hofman, R. De Maria
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
2024 L. Cantini, D. Trapani, L. Guidi, L. Boscolo Bielo, R. Scafetta, M. Koziej, L. Vidal, K.S. Saini, G. Curigliano
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2024 S. Loibl, F. André, T. Bachelot, C.H. Barrios, J. Bergh, H.J. Burstein, M.J. Cardoso, L.A. Carey, S. Dawood, L. Del Mastro, C. Denkert, E.M. Fallenberg, P.A. Francis, H. Gamal-Eldin, K. Gelmon, C.E. Geyer, M. Gnant, V. Guarneri, S. Gupta, S.B. Kim, D. Krug, M. Kater, I. Meattini, M. Morrow, W. Janni, S. Paluch-Shimon, A. Partridge, P. Poortmans, L. Pusztai, M.M. Regan, J. Sparano, T. Spanic, S. Swain, S. Tjulandin, M. Toi, D. Trapani, A. Tutt, B. Xu, G. Curigliano, N. Harbeck
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024 C. Valenza, T.M. De Pas, A. Gaeta, G. Castellano, C. Santoro, A. Corona, G. Chiappini, G. Vivanet, D. Trapani, S. Coppola, F. Conforti, D. Mattar, S. Gandini, P. Veronesi, E. Pennacchioli, G. Curigliano
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all
2024 D. Trapani, P.J. Garcia, L. Schroeder, R. Abdul-Ghani, A. Hansali, P.N. Offutalu, W. Sewell, S. Shakoor, L. Yunfeng, N. Hashimoto, F.G. Moussy, A. Aceves Capri, K. Fleming
Cardiotoxicity of Agents Used in Patients With Breast Cancer
2024 P. Zagami, D. Trapani, E. Nicolò, C. Corti, C. Valenza, C. Criscitiello, G. Curigliano, L.A. Carey
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
2024 S. Natangelo, D. Trapani, C. Koukoutzeli, L. Boscolo Bielo, G. Marvaso, B.A. Jereczek-Fossa, G. Curigliano
Biomarkers for antibody-drug conjugates in solid tumors
2024 J. Katrini, L. Boldrini, C. Santoro, C. Valenza, D. Trapani, G. Curigliano
A conceptual framework for cautious escalation of anticancer treatment: How to optimize overall benefit and obviate the need for de-escalation trials
2024 I. Pourmir, H.K. Van Halteren, R. Elaidi, D. Trapani, F. Strasser, G. Vreugdenhil, M. Clarke
The rise of immuno-oncology in China: a challenge to western dominance?
2023 M.P. Lythgoe, G. Lewison, A. Aggarwal, C. Booth, M. Lawler, D. Trapani, M. Sengar, R. Sullivan
Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives
2023 C. Valenza, G. Rizzo, M.I. Passalacqua, L. Boldrini, C. Corti, D. Trapani, G. Curigliano
Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and Reimbursement
2023 D. Trapani, Q. Jin, C.C. Block, R.A. Freedman, N.U. Lin, P. Tarantino, E.A. Mittendorf, T.A. King, S.C. Lester, J.E. Brock, N. Tayob, C.A. Bunnell, S.M. Tolaney, H.J. Burstein
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments
2023 C. Valenza, D. Trapani, S. Gandini, C. Sposetti, L. Boscolo Bielo, A. Marra, T. Giarratano, D. Favero, L. Cortesi, L. Moscetti, M. Pistelli, R. Berardi, A. Zambelli, M. Lambertini, L. Del Mastro, V. Guarneri, C. Vernieri, G. Curigliano
Adjuvant Chemotherapy in Older Women With Early Breast Cancer
2023 D. Trapani
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection
2023 D. Trapani, J. Sandoval, P.T. Aliaga, L. Ascione, P.P. Maria Berton Giachetti, G. Curigliano, O. Ginsburg
Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
2023 D. Trapani, E. Crimini, J. Sandoval, G. Curigliano
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology
2023 A.G. Leone, R. Miceli, D. Trapani, M. Massagrande, F. Morano, S. Marsoni, N. La Verde, R. Berardi, R. Casolino, M. Lambertini, D. Dalu, M. Di Maio, G.D. Beretta, F. Perrone, S. Cinieri, F. Pietrantonio
Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases
2023 P. Trillo, J. Sandoval, D. Trapani, E. Nicolò, P. Zagami, F. Giugliano, P. Tarantino, G. Vivanet, L. Ascione, A. Friedlaender, A. Esposito, C. Criscitiello, G. Curigliano